Navigation Links
LA BioMed researcher to receive prestigious honor

The American Association of Cardiovascular and Pulmonary Rehabilitation will bestow one of its highest honors on Los Angeles Biomedical Research Institute (LA BioMed) principal investigator, Richard Casaburi, PhD, MD, at the association's annual meeting in Milwaukee.

Dr. Casaburi, who holds the Alvin Grancell/Mary Burns Endowed Chair in the Rehabilitative Sciences at LA BioMed and leads its pulmonary rehabilitation research, will receive the Michael L. Pollock Established Investigator Award on Oct. 8 at the association's 25th Anniversary Celebration Banquet during its Annual Meeting in Milwaukee. In announcing the award, the association said it was recognizing Dr. Casaburi's "many outstanding contributions to cardiovascular and pulmonary rehabilitation."

The association, comprised of health professionals in the field of cardiac and pulmonary rehabilitation, is dedicated to reducing morbidity, mortality and disability from cardiovascular and pulmonary disease through education, prevention, rehabilitation, research and disease management.

"Congratulations to Dr. Casaburi for another milestone in his prestigious career in the field of respiratory research and pulmonary rehabilitation," said David I. Meyer, LA BioMed president and CEO. "Dr. Casaburi has led the way in developing new rehabilitation strategies for the millions suffering from respiratory disease. His research is another example of how LA BioMed's researchers are making a difference in the health and quality of life of patients around the world."

In addition to the Pollock award, Dr. Casaburi has received the California Medal from the American Lung Association of California; the Governors Award from the American College of Chest Physicians; the Mary Burns Award from the California Society for Pulmonary Rehabilitation; the Career Achievement Award from the Fourth Quebec International Symposium on Cardiopulmonary Prevention and Rehabilitation and an award from the American Thoracic Society for his contribution to the establishment of the society's Pulmonary Rehabilitation Assembly.

He is president of the Pulmonary Education and Research Foundation, a nonprofit corporation dedicated to advancing the scientific basis and practice of pulmonary rehabilitation. To date, he has authored 207 publications and 184 abstracts.

At LA BioMed, Dr. Casaburi directs the Rehabilitation Clinical Trials Center, a facility dedicated to performing clinical research aimed at improving the lives of patients with Chronic Obstructive Pulmonary Disease, the fourth leading cause of death in the United States.

In addition to his work at LA BioMed, Dr. Casaburi is associate chief for Research and professor of medicine in the Division of Respiratory and Critical Care Physiology and Medicine at Harbor-UCLA Medical Center. He is also director of Clinical Respiratory Physiology.

He received his PhD from Rensselaer Polytechnic Institute, before qualifying in medicine from the University of Miami, School of Medicine.

He is a Fellow of the American College of Chest Physicians and the American Association of Cardiovascular and Pulmonary Rehabilitation, and he is a member of the American Physiological Society and the American Thoracic Society. Dr. Casaburi currently serves on the editorial boards of the Journal of Cardiopulmonary Rehabilitation, Proceedings of the American Thoracic Society and the Journal of COPD.


Contact: Laura Mecoy
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)

Related medicine news :

1. BioMed Realty Trust Reports Fourth Quarter and Full-Year 2009 Financial Results
2. BioMed Realty Trust Promotes Matthew G. McDevitt to Executive Vice President, Real Estate
3. First Annual Bay Area Biomedical Device Conference to be Held at San Jose State University
4. Seattle BioMed Offers the Gift of Hope for Mother's Day
5. LA BioMed awarded research grant to study HIV prevention gel
6. Cambridge Healthtech Institute to Host Its Second Annual Collaborative Innovation in Biomedicine Conference
7. New Diagnostic Testing Company, Blue Ocean Biomedical, Specializes In Automated, Load & Go Cell Analysis Systems For Immune Monitoring
8. Manmade antibodies hold biomedical promise
9. Applied nuclear physics for biomedicine, nuclear security and basic science
10. Blue Ocean Biomedical Opens New Manufacturing Facility In Miramar, FL
11. Team led by LA BioMed scientist develops novel approach to study neurological disorders
Post Your Comments:
Related Image:
LA BioMed researcher to receive prestigious honor
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... that they are handling security in light of the recent terrorist attacks in Paris, ... attempt to stop an attack from reaching U.S. soil. Especially around special events that ...
(Date:11/27/2015)... ... 2015 , ... A team of Swiss doctors has released a report on ... just posted the findings on the website. Click here to read the details ... mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the 106 ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/25/2015)...  Linden Care, LLC, a retail specialty pharmacy focused ... suffering from chronic pain, said today that it is ... (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy ... --> --> The company said that ... --> --> In ...
Breaking Medicine Technology: